Across TCGA pan-cancer cohorts, SPACA6P-AS RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated SPACA6P-AS data layer compared with 6 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SPACA6P-AS RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SPACA6P-AS expression acts as an unfavorable survival marker, although some lineages such as SKCM and READ show a favorable association.
KIRC, KIRP, and BRCA are the cancer types where SPACA6P-AS RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.